Epileptic Encephalopathy In A Patient With A Novel Variant In The Kv7.2 S2 Transmembrane Segment: Clinical, Genetic, and Functional Features
Authors:
- Maria Virginia SoldovieriMSMaria Virginia Soldovieri
- Paolo AmbrosinoPAPaolo Ambrosino
- Ilaria MoscaIMIlaria Mosca
- Francesco MiceliFMFrancesco Miceli
- Cristina FrancoCFCristina Franco
- Lorella Maria Teresa CanzonieroLCLorella Maria Teresa Canzoniero
- Beth Kline-FathBKBeth Kline-Fath
- Edward C. CooperECEdward C. Cooper
- Charu VenkatesanCVCharu Venkatesan
- Maurizio TaglialatelaMTMaurizio Taglialatela
Open Access
- 10 July 2019
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (14) , 3382
Abstract
Kv7.2 subunits encoded by the KCNQ2 gene provide a major contribution to the M-current (IKM), a voltage-gated K+ current crucially involved in the regulation of neuronal excitability. Heterozygous missense variants in Kv7.2 are responsible for epileptic diseases characterized by highly heterogeneous genetic transmission and clinical severity, ranging from autosomal-dominant Benign Familial Neonatal Seizures (BFNS) to sporadic cases of severe epileptic and developmental encephalopathy (DEE). Here, we describe a patient with neonatal onset DEE, carrying a previously undescribed heterozygous KCNQ2 c.418G > C, p.Glu140Gln (E140Q) variant. Patch-clamp recordings in CHO cells expressing the E140Q mutation reveal dramatic loss of function (LoF) effects. Multistate structural modelling suggested that the E140Q substitution impeded an intrasubunit electrostatic interaction occurring between the E140 side chain in S2 and the arginine at position 210 in S4 (R210); this interaction is critically involved in stabilizing the activated configuration of the voltage-sensing domain (VSD) of Kv7.2. Functional results from coupled charge reversal or disulfide trapping experiments supported such a hypothesis. Finally, retigabine restored mutation-induced functional changes, reinforcing the rationale for the clinical use of Kv7 activators as personalized therapy for DEE-affected patients carrying Kv7.2 LoF mutations.Keywords
Funding Information
- Fondazione Telethon (GGP15113)
- Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN 2017ALCR7C, RBSI1444EM)
- Program STAR “Sostegno Territoriale alle Attività di Ricerca” (6-CSP-UNINA-120)
- Italian Ministry of Health Ricerca Finalizzata Giovani Ricercatori 2016 (GR-2016-02363337)
This publication has 53 references indexed in Scilit:
- The Kv7.2/Kv7.3 Heterotetramer Assembles with a Random Subunit ArrangementJournal of Biological Chemistry, 2012
- Altered Kv3.3 channel gating in early‐onset spinocerebellar ataxia type 13The Journal of Physiology, 2012
- Gating Currents from Kv7 Channels Carrying Neuronal Hyperexcitability Mutations in the Voltage-Sensing DomainBiophysical Journal, 2012
- State-dependent electrostatic interactions of S4 arginines with E1 in S2 during Kv7.1 activationJournal of General Physiology, 2010
- Selective Interaction of Syntaxin 1A with KCNQ2: Possible Implications for Specific Modulation of Presynaptic ActivityPLOS ONE, 2009
- The mutational spectrum of holoprosencephaly-associated changes within theSHHgene in humans predicts loss-of-function through either key structural alterations of the ligand or its altered synthesisHuman Mutation, 2009
- Atomic structure of a voltage-dependent K+ channel in a lipid membrane-like environmentNature, 2007
- Structural Insight into KCNQ (Kv7) Channel Assembly and ChannelopathyNeuron, 2007
- Oxidative modification of M‐type K+ channels as a mechanism of cytoprotective neuronal silencingThe EMBO Journal, 2006
- Determination of the subunit stoichiometry of a voltage-activated potassium channelNature, 1991